[Emerging infectious diseases--E coli O157 infections].
Nagayama
K
K
Kodama
T
T
Honda
T
T
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000930:Antidiarrheals; D001427:Bacterial Toxins / Q000633:toxicity; D000075202:Contraindications; D004927:Escherichia coli Infections / Q000150:complications / Q000382:microbiology; D019453:Escherichia coli O157 / Q000472:pathogenicity*; D006463:Hemolytic-Uremic Syndrome / Q000209:etiology / Q000628:therapy; D006801:Humans; D010276:Parasympatholytics; D006435:Renal Dialysis; D022622:Shiga Toxin 1
D000900:Anti-Bacterial Agents; D000930:Antidiarrheals; D001427:Bacterial Toxins; D010276:Parasympatholytics; D022622:Shiga Toxin 1